Advertisement

Topics

Sunovion Submits Supplemental New Drug Application to FDA for Use of APTIOM® (eslicarbazepine acetate) for the Treatment of Partial-Onset Seizures in Children 4 Years of Age and Older

09:00 EDT 13 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
- If approved, APTIOM® would provide an important new monotherapy or adjunctive therapy treatment option for individuals as early as four years of age who experience partial-onset seizures - Sunovion Pharmaceu...

Other Sources for this Article

Sunovion Pharmaceuticals Inc.
Kristina Coppola, 508-787-4368
Sr. Manager, Corporate Communications
kristina.coppola@sunovion.com

NEXT ARTICLE

More From BioPortfolio on "Sunovion Submits Supplemental New Drug Application to FDA for Use of APTIOM® (eslicarbazepine acetate) for the Treatment of Partial-Onset Seizures in Children 4 Years of Age and Older"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...